| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 700128 | Null | 0.0385613993886001 | 0.30619018 |
| NSC 700455 | Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- | 0.0385613993886001 | 0.44223895 |
| NSC 703037 | Null | 0.0385613993886001 | -0.089666873 |
| NSC 710716 | Null | 0.0385613993886001 | 0.41892655 |
| NSC 71669 | Null | 0.0385613993886001 | 0.3973132 |
| NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.0385613993886001 | 0.52962402 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0385613993886001 | 0.41641246 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0385613993886001 | 0.18835957 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0385613993886001 | 0.47230076 |
| NSC 735030 | Null | 0.0385613993886001 | 0.29060909 |